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ABSTRACT The CDC7 protein of Saccharomyces cerevi-
siae may be involved in the G1/S-phase transition and/or in
the initiation of mitotic DNA synthesis. The CDC7 gene has two
in-frame AUG codons as possible translation start sites, which
would produce 58- and 56-kDa proteins, respectively. Both p58
and p56 derived from recombinant plasmids complement the
temperature-sensitive growth defect of the cdc7-1 allele. To
determine the biochemical function of the CDC7 protein, the
CDC7 gene was cloned and polyclonal antibodies were pro-
duced against the CDC7 protein. CDC7 immune complexes
prepared from yeast with these antibodies phosphorylate his-
tone H1. Kinase activity is thermolabile in strains carrying the
cdc7-1 temperature-sensitive mutant allele and is elevated
>10-fold in strains carrying plasmids overexpressing either
p56 or p58, confirming that the kinase in the immunopre-
cipitates is the CDC7 gene product. In addition, we show that
CDC7 is a phosphoprotein itself. Indirect immunofluorescence
and biochemical fractionation show that the CDC7 protein is
present at relatively high concentrations in the nucleus com-
pared with the cytoplasm, suggesting that nuclear proteins may
be substrates for the CDC7 protein.
Two major events define the eukaryotic cell cycle: replication
of the chromosomes during S phase and segregation of the
chromosomes during mitosis. Replication and segregation
are separated by two gap periods, G1 and G2, during which
the cells prepare for these events. There are also two major
control points for the cell cycle in G1 and G2, the point of
commitment to DNA synthesis in G1 and the regulation of
progression into mitosis in G2. Although we have made great
strides in understanding mitotic control in the past three
years, relatively little is known about the events in G1 that
lead to S phase. In yeast, the point of commitment to DNA
synthesis is defined as "Start", early in G1. DNA synthesis
does not ensue immediately after Start, however, and it is not
clear whether the lag is due to assembly of the replication
apparatus or to a cascade of controls initiated at Start.
CDC28, CDC4, and CDC7 define a dependent series of
events set in motion at Start (1-3). CDC28 encodes a protein
kinase subunit, the analog of the highly conserved cdc2+/
MPF kinase subunit involved in regulation of mitosis (3).
CDC4 is homologous to one subunit of the signal transducing
protein, transducin (4). The DNA sequence of the CDC7 gene
predicts a protein that has homology to catalytic domains of
the protein kinases CDC2/CDC28, NIM1, and a number of
kinase-related transforming proteins (5). The CDC7 sequence
differs from that of other protein kinases in the so-called
phosphate acceptor domain, however (5, 6).
We have been interested in the role of CDC7 in the events
linking Start and the initiation ofDNA replication. Mutations
in CDC7 appear to block a precondition for DNA synthesis
because cells carrying these lesions cannot start new rounds
of DNA replication after a shift from permissive to nonper-
missive temperature (7, 8). The cdc7 mutation arrests cells at
the late G1/S-phase boundary, prior to the initiation of DNA
synthesis, and shows the dumbbell-shaped terminal pheno-
type typically associated with a DNA synthesis or nuclear
division defect (7, 9). Cycloheximide does not inhibit initia-
tion and completion of DNA synthesis when added after
return of cdc7 cells from the restrictive to the permissive
temperature (10), suggesting that all protein synthesis late in
G1 essential for initiation of DNA replication can be com-
pleted during the cdc7 block. The phenotype of cdc7 mutants
would be consistent with CDC7 mediating an important signal
for initiation of replication or with CDC7 participating in
initiation itself. The function of the CDC7 protein in the Gu/S
transition and/or in the initiation of mitotic DNA replication
may be accomplished by its protein kinase activity, for
instance by periodically activating a crucial replication pro-
tein. This would imply that the function of CDC7 itself must
be periodically regulated. Since overall levels of CDC7 RNA
and protein do not seem to be limiting for entry into S phase
(11), fluctuation in CDC7 levels does not account for its
periodic function. Thus, either the activity of CDC7 itself
must change during the cell cycle, or its location in the cell
may vary, or there is a periodic change in a protein with which
it interacts-for instance, a substrate.
To investigate whether the activity of CDC7 changes
during the cell cycle, we wished to define its biochemical
activity and to devise an assay that could be used to follow
CDC7 activity through the cell cycle. In this paper, we show
that the CDC7 protein contains protein kinase activity that
can be measured specifically in nuclear extracts using histone
H1 as substrate. We also show that the CDC7 protein is
modified by phosphorylation and that it is located in the
nucleus.
MATERIALS AND METHODS
Strains. Saccharomyces cerevisiae strains were SEY6210
(MATa his3-A200 lys2-801 trpl-A901 ura3-52 suc2-A9 leu2-
3,112) and YC7379 (MATa adel his7 lys2 tyrl ura3-52 cdc7-
1). Strain SEY6210 was obtained from S. D. Emr (California
Institute of Technology, Pasadena, CA) and strain YC7379
was constructed for this work.
Production of CDC7 Antisera. The CDC7 gene was intro-
duced into Escherichia coli using the ptac expression vector,
pKK223-3 (12). Briefly, the gene was brought under the
control of the tac promoter by inserting the Cla I/EcoRI
fragment from CDC7 into the EcoRI site of the vector, and
reconstituting the CDC7 coding sequence with the oligonu-
cleotide 5'-AA TTC ATG ACA AGC AAA ACG AAG AAT
AT-3'. The protein was partially purified by chromatography
on DEAE-cellulose (Whatman) and heparin-agarose col-
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umns. Bands corresponding to the CDC7 protein were ex-
cised from SDS/polyacrylamide gels and used for immuni-
zation of two rabbits whose sera were free of anti-yeast IgG.
Multiple injections were given until the CDC7 protein was
detected on immunoblots of yeast extracts. A 1:600 dilution
of antibody is sufficient to detect 50 ng of CDC7 protein by
protein blotting.
Indirect Immunofluorescence of Yeast Cells. This procedure
is based on the techniques developed by Kilmartin and
coworkers for whole-mount yeast cells (13, 14) and modified
from the procedure as described (15).
Isolation ofYeast Nuclei. Yeast nuclei were prepared by the
method of Hurt et al. (16). The nuclear pellet was resus-
pended in 50 ml of Percoll gradient buffer containing 50%o
Percoll (Pharmacia), 40 mM Pipes (pH 6.5), 5 mM MgCl2, 0.5
mM phenylmethylsulfonyl fluoride (PMSF) and centrifuged
in a Beckman VTi5O rotor at 21,000 rpm for 40 min. Three
bands were shown after centrifugation. The nuclear band was
in the middle of the gradient and was collected by inserting
a needle into that position. The nuclear fraction was diluted
with 3 vol of 40 mM Pipes, pH 6.5/5 mM MgCl2/0.5 mM
PMSF and centrifuged at 12,000 rpm for 20 min to remove
Percoll.
Immunoprecipitation and Protein Kinase Assays. Nuclear
fractions were prepared as described above except the Per-
coll gradient step was not performed. Crude nuclei were
resuspended in 50mM Tris-HCl, pH 7.5/10mM MgCl2/1 mM
dithiothreitol/1 mM PMSF, and 4M (NH4)2SO4 was added to
0.4 M final concentration. The lysate was spun at 100,000 x
g for 30 min. The supernatant was precipitated with ammo-
nium sulfate (70%o saturation) and centrifuged at 100,000 X g
for 20 min. The pellet was dissolved in 3 ml of 15% (wt/vol)
sucrose/50 mM Tris-HCI, pH 7.5/50 mM NaCl/0.1% Triton
X-100/1 mM dithiothreitol/0.5 mM PMSF, dialyzed against
the same buffer, and frozen in aliquots at -70°C until needed.
Immunoprecipitations and protein kinase assays were per-
formed as described by Reed et al. (3) with some modifica-
tions. Ten microliters of preimmune serum was added to 20
,ul of a protein A-Sepharose (100 mg/ml) suspension and
incubated for 1 hr at 4°C. The beads were collected by
centrifugation and resuspended with 0.5 mg of cytosolic or
nuclear fractions from various yeast cultures. After 1 hr at
4°C, the suspension was centrifuged and the supernatant was
transferred to another tube. The pellet contained preimmune
complexes and was saved for further assays. The supernatant
was used for a second immunoprecipitation with 10 ,ul of
CDC7 antisera. Then, the preimmune and CDC7 immune
complexes were washed twice in 50 mM TrisHCI, pH
7.5/150 mM NaCI/0.5% Tween 20/0.2 mM EDTA, followed
by two washes in 0.5 M LiCI/0.1 M Tris HCI, pH 7.5, and
finally by two washes with 25 mM Tris HCl, pH 7.5/5 mM
NaF/10 mM MgCI2/0.1 mM EGTA/0.5 mM PMSF (reaction
buffer). The beads were resuspended in 30 ,ul of the reaction
buffer. For kinase assays, 2 ,ug of histone HI (Boehringer
Mannheim) was added to 30 ,ul of redissolved immunopre-
cipitate along with 300 p.M [y32P]ATP (0.3 ,uCi/nmol; 1 Ci =
37 GBq). After 15 min at 37°C, reactions were terminated by
the addition of SDS sample buffer, and phosphorylated
products were analyzed by electrophoresis on SDS/
polyacrylamide gels.
RESULTS
Overexpression of CDC7 in Yeast. The CDC7 gene was
isolated by transformation of a ura3-52 cdc7-1 strain of S.
cerevisiae with a YCp5O yeast genomic library constructed in
our lab (17). To define the catalytic activity of the CDC7
protein, we used the cloned gene to facilitate isolation of the
CDC7 protein from E. coli and yeast. The CDC7 protein
expressed in E. coli using three different expression systems
was not active as a protein kinase with any substrates tested
(data not shown). Since we were unable to demonstrate
CDC7 kinase activity in E. coli, we reasoned that there might
be a specific modification of the protein or a specific cofactor
only found in yeast. Therefore, we next undertook to isolate
the protein from yeast. For this purpose, we cloned CDC7 in
a GAL10 expression vector. The nucleotide sequence of
CDC7 contains two in-frame ATG codons, one at nucleotide
1 and the other at nucleotide 55. The gene product arising
from the first ATG in CDC7 is called p58, and the one from
its second ATG is called p56. Since it is not known which
ATG is used in vivo, we produced both p58 and p56. The
entire CDC7 gene was inserted into the unique EcoRI site of
the GAL expression vector pSEY18*Gal (S. D. Emr), a high
copy number vector that allows inducible expression of the
CDC7 protein. The fragment carrying the CDC7 gene was
created by ligation of a synthetic linker (EcoRI ATG ACA
AGC AAA ACG AAG AAT Cla I), representing the first
seven amino acids of CDC7, to the 2.4-kilobase Cla IlEcoRI
fragment of CDC7. To express p56, the first ATG was
removed by cutting at the Cla I site, which lies between the
two initiation codons, followed by further deletion with
BAL-31 of the DNA between that Cla I site and the second
ATG. The plasmids encoding p58 and p56 were named
pSYC7S8 and pSYC756, respectively. Both plasmids were
able to complement the mitotic growth defect in cdc7-1 cells
at the nonpermissive temperature.
CDC7 protein expressed from these plasmids was analyzed
by protein blotting and immunoprecipitation of 35S-labeled
yeast cells. As shown in Fig. 1, yeast strains carrying
pSYC758 and pSYC756 produced CDC7-encoded proteins of
58 and 56 kDa, respectively. Strong signals were obtained
only after galactose induction (lanes e, f, and h). Thus, the
CDC7 protein may be present at very low levels in wild-type
cells.
Protein Kinase Activity of the CDC7 Gene Product Isolated
from Yeast. Because of the low levels of CDC7 protein
present in whole cell extracts of wild-type cells and because
the overproduced protein was difficult to solubilize, conven-
tional purification was inefficient. CDC7 protein was there-
fore immunoprecipitated from both nuclear and cytosolic
fractions of various yeast strains, and the redissolved im-
munoprecipitates were used in protein kinase assays with calf
thymus histone H1 as the substrate. As shown in Fig. 2,
histone H1 is clearly phosphorylated by immunoprecipitates
prepared from nuclear extracts with CDC7 antisera, suggest-
ing that the CDC7 protein contains protein kinase activity.
Since to preserve enzymatic activity immunoprecipitates
must be prepared under conditions in which additional pro-
teins may coprecipitate (although we removed proteins in-
teracting nonspecifically with the rabbit IgG by first precip-
itating with preimmune sera), to ensure that the kinase
activity observed was due to the CDC7-encoded protein and
not to a contaminating kinase, two control experiments were
carried out. First, we demonstrated overproduction of kinase
activity in extracts ofcdc7-1 mutant strains carrying plasmids
pSYC758 and pSYC756 compared with extracts of the same
strain carrying vector alone. Comparison of lanes c, d, and e
in Fig. 2 indicates that the level of kinase activity was
>10-fold higher in the CDC7 overproducer than in a strain
containing vector alone. The magnitude of overproduction
was estimated from four independent experiments and den-
sitometer tracings of the autoradiograms. Since these assays
measure extents of phosphorylation rather than initial rates,
this is a minimum estimate of the actual overproduction.
Second, we demonstrated that the kinase activity was ther-
molabile in immunoprecipitates prepared from cdc7-1 mu-
tants. Comparison of lanes b and c in Fig. 2 shows that the
kinase activity is thermolabile in the strain carrying vector
alone (QW = 0.2). Conversely, in the same strains carrying
Biochemistry: Yoon and Campbell
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FIG. 1. Characterization of CDC7 antibody by immunoblot and
immunoprecipitation. (Left) Stationary cultures of yeast strain
SEY6210/pG12/pSEY18-Gal (lanes a and d), and the CDC7-
overproducing strains SEY6210/pG12/pSYC756 (lanes b and e), and
SEY6210/pG12/pSYC758 (lanes c and f) grown in synthetic com-
plete (SC) medium (minus uracil and leucine) plus 2% glucose were
diluted 1:10 in SC medium (minus uracil and leucine) containing
either 2% glucose (lanes a-c) or 2% galactose (lanes d-f). Plasmid
pG12 provides the GAL4 protein essential for expression from the
GAL10 promoter (18). After 8 hr at 30°C, whole yeast lysates were
prepared by disruption of the cells with glass beads and clarified by
centrifugation. The pellets were resuspended in buffer containing 1%
SDS and analyzed on a SDS/109% polyacrylamide gel. Proteins were
then electroblotted to a nitrocellulose membrane. This immunoblot
was stained with anti-CDC7 antiserum at a dilution of 1:250 and
visualized by using the Bio-Rad Immun-Blot assay kit (goat anti-
rabbit IgG horseradish peroxidase conjugate). (Right) For labeling
with [35S]methionine (Tran35S-label, ICN), strain SEY6210/pG12/
pSYC758 was grown in SC medium (minus uracil, leucine, and
methionine) plus 2% glucose, to 2 x 107 cells per ml. Cells were
harvested, washed twice, and resuspended in the same medium
containing 2% galactose. After 1 hr at 30°C, 250 ,uCi of [35S]methio-
nine was added and the incubation continued for 40 min. Cells were
lysed in 100 ,ul of 50 mM Tris HCl, pH 7.5/1 mM EDTA/1% SDS by
Vortex mixing in the presence of glass beads followed by boiling for
5 min. The lysate was diluted by the addition of 1 ml ofbuffer (50mM
Tris HCl, pH 7.5/150mM NaCl/0.1 mM EDTA/0.5% Tween 20) and
centrifuged, and the supernatant was used for immunoprecipitation
with 5 ,ul of preimmune serum (lane g) or 5 ,l of CDC7 antiserum
(lane h). Samples were analyzed by electrophoresis in SDS/10%
polyacrylamide gel.
CDC7-containing plasmids, kinase activity at 37°C is at least
2-fold higher than at 23°C [lanes f and g (Q3 = 2)], indicating
that the thermolability observed in lanes b and c is not due to
nonspecific factors in the strain background affecting kinase
activity at 37°C vs. 23°C and that the kinase is associated with
the CDC7 gene product. We could not detect CDC7-
dependent phosphorylation ofhistones with preimmune com-
plexes (data not shown).
CDC7 Is a Phosphoprotein. In immunoprecipitates from
strains overproducing p58 and p56, in addition to phosphor-
ylation of histone H1, a protein of 58 or 56 kDa, respectively,
was also phosphorylated. As shown in Fig. 3, phosphoryla-
tion of these 56- and 58-kDa proteins was detectable only in
nuclear and not in cytoplasmic extracts. It is likely that these
proteins are the CDC7 gene product. The 48-kDa band that
appears in this experiment was also seen in immunopre-
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FIG. 2. CDC7-dependent phosphorylation of histone H1. Nu-
clear extracts were prepared from strain YC7379 (cdc7-1), carrying
pSEY18 Gal, pSYC756, or pSYC758. Cells were grown at 230C and
proteins (0.5 mg) were immunoprecipitated twice: proteins interact-
ing nonspecifically with the rabbit IgG were removed by precipitating
with preimmune serum and the supernatant was subjected to a
second immunoprecipitation with CDC7 immune antiserum. The
final pellet was preincubated at 230C (lanes b and f) and 370C (lanes
a, c, d, e, and g). After 30 min, 2 ,ug of histone H1 and 300 AM[y-132P]ATP were added and incubation continued for 15 min. Reac-
tion products were analyzed on a SDS/10%o polyacrylamide gel,
stained with Coomassie blue, dried, and autoradiographed. Lanes: a,
histone Hi alone; b, YC7379/pSEY18-Gal, 23°C; c, YC7379/
pSEY18 Gal, 37°C; d, YC7379/pSYC756, 37°C; e, YC7379/
pSYC758, 37°C; f, YC7379/pSYC758, 23°C; g, YC7379/pSYC758,
370C.
cipitates prepared with preserum and may represent a con-
taminant (such as IgG), or it may be an activator or a
substrate of CDC7.
The observed phosphorylation ofp56 and p58 by the CDC7
immunoprecipitates could be due either to autophosphory-
lation or to a coprecipitating kinase. The results suggested,
however, that CDC7 might occur in vivo as a phosphoprotein.
To investigate the latter possibility, cells carrying pSYC758
were grown on galactose, labeled with 32Pi, and immunopre-
cipitated with CDC7 antisera. As shown in Fig. 3 (lane i),
strains overproducing p58 do contain a 58-kDa phosphopro-
tein. This protein is not observed in the absence of overpro-
duction (lane j) or in extracts precipitated with preimmune
serum (lane k).
Localization of the CDC7 Gene Product by Indirect Immu-
nofluorescence and Subcellular Fractionation. Knowledge of
the subcellular localization of the CDC7 protein may be
useful in establishing its molecular function by narrowing the
range of potential substrates and cellular proteins with which
it interacts. Using indirect immunofluorescence microscopy
with CDC7 antisera, we found intense immunofluorescence
in the nuclei of CDC7-overproducing cells (Fig. 4A). Fainter
but distinct immunofluorescence was also seen in the cyto-
plasm. In the experiment shown, cells were also stained with
Hoechst 33258 to verify the position of the nuclei (Fig. 4B).
However, identical staining patterns were observed in other
experiments in which only anti-CDC7 staining and Nomarsky
optics were used, and therefore the patterns are not due to
leakage from the additional dye. Thus, the CDC7 protein
appears to be present in both the cytoplasm and nucleus but
to be relatively concentrated in the nucleus. Only faint
Proc. Natl. Acad. Sci. USA 88 (1991)
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FIG. 3. Phosphorylation of the CDC7 protein in vivo and in vitro.
(Left) Proteins (0.5 mg) of nuclear (lanes a-d) and cytosolic (lanes
e-h) fractions were immunoprecipitated twice as described in Fig. 2
and incubated for 30 min at 37°C in the presence of 10 ,uCi of
[y-32P]ATP (3000 Ci/mmol; Amersham). Samples were analyzed on
a SDS/10o polyacrylamide gel. Lanes: a and e, SEY6210/pG12/
pSYC758; b and f, SEY6210/pG12/pSYC756; c and g, SEY6210/
pG12/pSEY18&Gal; d and h, YC7379/pSEY18.Gal. (Right) 32p-
labeled CDC7 immunoprecipitates were prepared as follows: 5 x 107
cells of strain SEY6210/pG12/pSEY18-Gal (lane j) or SEY6210/
pG12/pSYC758 (lanes i and k) were labeled for 1 hr with 0.5 mCi of
[32P]orthophosphate (New England Nuclear) in reduced phosphate
minimal medium (19) containing 2% galactose. Cell lysis and immu-
noprecipitation were performed as described in the legend to Fig. 1
except that either 10 Al ofpreimmune serum (lane k) or 10 ,u1 ofCDC7
immune antiserum (lanes i and j) was used.
CDC7-specific immunofluorescence was detected when cells
carrying the vector pSEY18-Gal were stained with CDC7
antisera in an identical manner (data not shown). The diffi-
culty in visualizing CDC7 antigen in the absence of overpro-
duction suggests that the levels of CDC7 protein in yeast are
low, in accord with the immunoblot analysis (Fig. 1, lanes a
and d).
FIG. 5. Localization of CDC7 by subcellular fractionation. Pro-
teins (100 ug) of nuclear (lanes a-d) and cytosolic (lanes e-h)
fractions were separated by a SDS/10%o polyacrylamide gel, elec-
troblotted to nitrocellulose, and stained with anti-CDC7 antiserum
(diluted 1:250). Arrows on the left indicate the immunoblot bands for
CDC7-p58 and CDC7-p56, respectively. Lanes: a and e, SEY6210/
pG12/pSYC758; b and f, SEY6210/pG12/pSYC756; c and g,
SEY6210/pG12/pSEY18-Gal; d and h, YC7379/pSEY18-Gal.
The nuclear localization of the CDC7 protein was corrob-
orated by biochemical fractionation. Fig. 5 shows immuno-
blot analysis of CDC7 protein in cytosolic and nuclear
fractions. Equal amounts of protein, rather than equal num-
bers of cell equivalents, were loaded in each lane, because of
the difficulty of quantitating cell equivalents due to uncer-
tainty in measurement of losses experienced during the
purification of nuclei. These results demonstrate, however,
that CDC7 is relatively concentrated in the Percoll gradient-
purified nuclei. When 5-fold excess of cytosolic protein is
analyzed, CDC7 is detectable (data not shown). We estimate
that both p58 and p56 were present in at least 20-fold higher
concentrations in nuclear fractions than in cytosolic fractions
(Fig. 5). ABF1 and SSB1, nuclear proteins previously studied
in this lab (20, 21), were also observed in our nuclear fractions
only (data not shown). Comparison of the CDC7 sequence
with the nuclear targeting signal consensus revealed putative
nuclear localization signals in at least six different positions.
FIG. 4. Subcellular localization of the CDC7 protein. Yeast strain SEY6210/pG12/pSYC758 was grown to stationary phase in synthetic
complete (SC) medium (minus uracil and leucine) plus 2% glucose. Cells were harvested, washed twice with SC medium (minus uracil and
leucine) containing 2% galactose, and resuspended in the same medium. At OD6w = 0.4, cells were fixed with formaldehyde, digested with
3-glucuronidase and zymolyase 100T, immobilized on polylysine-coated slides, and stained with polyclonal anti-CDC7 antiserum (A) and
Hoechst 33258 (B). (A) Viewing was under rhodamine excitation wavelength. (B) Yeast nuclei were visualized by staining with the dye Hoechst
33258. (Bar = 10,m.)
Biochemistry: Yoon and Campbell
3578 Biochemistry: Yoon and Campbell
DISCUSSION
The phenotype of S. cerevisiae cdc7 mutants suggests that
the CDC7 gene product has multiple functions. CDC7 may be
involved in the initiation of mitotic DNA synthesis, premei-
otic recombination, formation ofascospores, and error-prone
DNA repair (22, 23). To date, however, the molecular roles
of CDC7 in those events have not been characterized. As a
step toward investigating the functions of CDC7 in yeast, we
have identified the CDC7 protein as a protein kinase in
vegetatively growing yeast cells. [While our work was in
review, a similar result was presented by others (24), al-
though kinase activity could only be observed after overpro-
duction.] We have also shown that the CDC7 protein is
phosphorylated in vivo and is found in the nucleus as well as
in the cytoplasm. The demonstration of protein kinase ac-
tivity in the CDC7 protein is consistent with preliminary
experiments showing that in vitro transcription and transla-
tion ofthe CDC7gene produces a protein kinase activity (25).
CDC7 appears to be present at low abundance in yeast as
predicted from the codon utilization analysis of the CDC7
open reading frame. We have, however, found a very faint
band of p58 in immunoblot analysis performed with nuclear
extracts of wild-type yeast strains when alkaline phosphatase
conjugates were used to visualize the CDC7 protein (unpub-
lished data).
As suggested by the amino acid sequence, the CDC7
protein seems to carry a protein kinase activity. Using
exogenous histone H1 as a substrate, we demonstrated
protein kinase activity in CDC7 immunoprecipitates of nu-
clear extracts of wild-type cells without overproduction. The
histone phosphorylation was thermolabile in cdc7-1 extracts
and phosphorylation was proportional to the amount of p58
present. Elevated kinase levels in the strain overproducing
p56 suggest that p56, as well as p58, is active as a kinase. In
addition to acting as protein kinases, both p56 and p58 also
appear to be substrates of a phosphorylating activity in the
immunoprecipitates. It is not yet clear whether this repre-
sents autophosphorylation or coprecipitation of another ki-
nase. Our finding that CDC7 protein is a phosphoprotein in
vivo suggests that the in vitro phosphorylation may be
physiologically significant.
According to indirect immunofluorescence and subcellular
fractionation studies, both forms of CDC7 are concentrated
in the nuclei of CDC7-overproducing cells. We are not sure
whether the staining patterns reflect a role for-CDC7 in both
the cytoplasm and nucleus or if they simply result from the
delocalization of the exclusively nuclear protein due to
overproduction. The demonstration that CDC7 is associated
with the nuclei of mitotic cells suggests that CDC7 may
function in the mitotic cell cycle by phosphorylating proteins
involved in the initiation of DNA synthesis and/or in the
G1/S-phase transition.
Although basal level expression requires an element in the
promoter that is homologous to a c-fos-activating sequence,
CDC7 mRNA remains at a constant level throughout the cell
cycle when measured in cells released from a-factor arrest
(11, 26). Furthermore, indirect evidence suggests that the
CDC7 protein exists in excess of the amount required for a
single mitotic cell division (11). Yet CDC7 is required at a
discrete point in the cycle. It will be of interest to investigate
whether phosphorylation of CDC7 protein, translocation to
the nucleus, catalytic activity of the CDC7 protein kinase,
and/or availability of a crucial substrate is regulated through
the cell cycle.
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